Global Recombinant Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.
These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.
Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.
According to our (Global Info Research) latest study, the global Recombinant Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.
This report is a detailed and comprehensive analysis for global Recombinant Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc, Green Cross Corporation, Pfizer Inc., Bayer AG and Sanofi S A., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombinant Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Recombinant Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Vaccines, with price, sales, revenue and global market share of Recombinant Vaccines from 2018 to 2023.
Chapter 3, the Recombinant Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Vaccines.
Chapter 14 and 15, to describe Recombinant Vaccines sales channel, distributors, customers, research findings and conclusion.
These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.
Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.
According to our (Global Info Research) latest study, the global Recombinant Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.
This report is a detailed and comprehensive analysis for global Recombinant Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc, Green Cross Corporation, Pfizer Inc., Bayer AG and Sanofi S A., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombinant Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Subunit Recombinant Vaccines
- Attenuated Recombinant Vaccines
- Vector Recombinant Vaccines
- Recombinant Human Vaccines
- Animal Recombinant Vaccines
- Merck & Co., Inc
- Green Cross Corporation
- Pfizer Inc.
- Bayer AG
- Sanofi S A.
- Protein Science Corporation
- GlaxoSmithKline Plc.
- Novartis AG
- Bharat Biotech
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Recombinant Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Vaccines, with price, sales, revenue and global market share of Recombinant Vaccines from 2018 to 2023.
Chapter 3, the Recombinant Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Vaccines.
Chapter 14 and 15, to describe Recombinant Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Subunit Recombinant Vaccines
1.3.3 Attenuated Recombinant Vaccines
1.3.4 Vector Recombinant Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Recombinant Human Vaccines
1.4.3 Animal Recombinant Vaccines
1.5 Global Recombinant Vaccines Market Size & Forecast
1.5.1 Global Recombinant Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombinant Vaccines Sales Quantity (2018-2029)
1.5.3 Global Recombinant Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck & Co., Inc
2.1.1 Merck & Co., Inc Details
2.1.2 Merck & Co., Inc Major Business
2.1.3 Merck & Co., Inc Recombinant Vaccines Product and Services
2.1.4 Merck & Co., Inc Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & Co., Inc Recent Developments/Updates
2.2 Green Cross Corporation
2.2.1 Green Cross Corporation Details
2.2.2 Green Cross Corporation Major Business
2.2.3 Green Cross Corporation Recombinant Vaccines Product and Services
2.2.4 Green Cross Corporation Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Green Cross Corporation Recent Developments/Updates
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Recombinant Vaccines Product and Services
2.3.4 Pfizer Inc. Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Inc. Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Recombinant Vaccines Product and Services
2.4.4 Bayer AG Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Sanofi S A.
2.5.1 Sanofi S A. Details
2.5.2 Sanofi S A. Major Business
2.5.3 Sanofi S A. Recombinant Vaccines Product and Services
2.5.4 Sanofi S A. Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi S A. Recent Developments/Updates
2.6 Protein Science Corporation
2.6.1 Protein Science Corporation Details
2.6.2 Protein Science Corporation Major Business
2.6.3 Protein Science Corporation Recombinant Vaccines Product and Services
2.6.4 Protein Science Corporation Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Protein Science Corporation Recent Developments/Updates
2.7 GlaxoSmithKline Plc.
2.7.1 GlaxoSmithKline Plc. Details
2.7.2 GlaxoSmithKline Plc. Major Business
2.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Product and Services
2.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Plc. Recent Developments/Updates
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Recombinant Vaccines Product and Services
2.8.4 Novartis AG Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Novartis AG Recent Developments/Updates
2.9 Bharat Biotech
2.9.1 Bharat Biotech Details
2.9.2 Bharat Biotech Major Business
2.9.3 Bharat Biotech Recombinant Vaccines Product and Services
2.9.4 Bharat Biotech Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bharat Biotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT VACCINES BY MANUFACTURER
3.1 Global Recombinant Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombinant Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombinant Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Recombinant Vaccines Manufacturer Market Share in 2022
3.5 Recombinant Vaccines Market: Overall Company Footprint Analysis
3.5.1 Recombinant Vaccines Market: Region Footprint
3.5.2 Recombinant Vaccines Market: Company Product Type Footprint
3.5.3 Recombinant Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant Vaccines Market Size by Region
4.1.1 Global Recombinant Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Recombinant Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Recombinant Vaccines Average Price by Region (2018-2029)
4.2 North America Recombinant Vaccines Consumption Value (2018-2029)
4.3 Europe Recombinant Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant Vaccines Consumption Value (2018-2029)
4.5 South America Recombinant Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Recombinant Vaccines Consumption Value by Type (2018-2029)
5.3 Global Recombinant Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Recombinant Vaccines Consumption Value by Application (2018-2029)
6.3 Global Recombinant Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Recombinant Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Recombinant Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Recombinant Vaccines Market Size by Country
7.3.1 North America Recombinant Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Recombinant Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Recombinant Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Recombinant Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant Vaccines Market Size by Country
8.3.1 Europe Recombinant Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombinant Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombinant Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant Vaccines Market Size by Region
9.3.1 Asia-Pacific Recombinant Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombinant Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Recombinant Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Recombinant Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Recombinant Vaccines Market Size by Country
10.3.1 South America Recombinant Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Recombinant Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombinant Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant Vaccines Market Size by Country
11.3.1 Middle East & Africa Recombinant Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Recombinant Vaccines Market Drivers
12.2 Recombinant Vaccines Market Restraints
12.3 Recombinant Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Vaccines
13.3 Recombinant Vaccines Production Process
13.4 Recombinant Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Vaccines Typical Distributors
14.3 Recombinant Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Recombinant Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Subunit Recombinant Vaccines
1.3.3 Attenuated Recombinant Vaccines
1.3.4 Vector Recombinant Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Recombinant Human Vaccines
1.4.3 Animal Recombinant Vaccines
1.5 Global Recombinant Vaccines Market Size & Forecast
1.5.1 Global Recombinant Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombinant Vaccines Sales Quantity (2018-2029)
1.5.3 Global Recombinant Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck & Co., Inc
2.1.1 Merck & Co., Inc Details
2.1.2 Merck & Co., Inc Major Business
2.1.3 Merck & Co., Inc Recombinant Vaccines Product and Services
2.1.4 Merck & Co., Inc Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck & Co., Inc Recent Developments/Updates
2.2 Green Cross Corporation
2.2.1 Green Cross Corporation Details
2.2.2 Green Cross Corporation Major Business
2.2.3 Green Cross Corporation Recombinant Vaccines Product and Services
2.2.4 Green Cross Corporation Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Green Cross Corporation Recent Developments/Updates
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Recombinant Vaccines Product and Services
2.3.4 Pfizer Inc. Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Inc. Recent Developments/Updates
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Recombinant Vaccines Product and Services
2.4.4 Bayer AG Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer AG Recent Developments/Updates
2.5 Sanofi S A.
2.5.1 Sanofi S A. Details
2.5.2 Sanofi S A. Major Business
2.5.3 Sanofi S A. Recombinant Vaccines Product and Services
2.5.4 Sanofi S A. Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi S A. Recent Developments/Updates
2.6 Protein Science Corporation
2.6.1 Protein Science Corporation Details
2.6.2 Protein Science Corporation Major Business
2.6.3 Protein Science Corporation Recombinant Vaccines Product and Services
2.6.4 Protein Science Corporation Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Protein Science Corporation Recent Developments/Updates
2.7 GlaxoSmithKline Plc.
2.7.1 GlaxoSmithKline Plc. Details
2.7.2 GlaxoSmithKline Plc. Major Business
2.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Product and Services
2.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GlaxoSmithKline Plc. Recent Developments/Updates
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Recombinant Vaccines Product and Services
2.8.4 Novartis AG Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Novartis AG Recent Developments/Updates
2.9 Bharat Biotech
2.9.1 Bharat Biotech Details
2.9.2 Bharat Biotech Major Business
2.9.3 Bharat Biotech Recombinant Vaccines Product and Services
2.9.4 Bharat Biotech Recombinant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bharat Biotech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT VACCINES BY MANUFACTURER
3.1 Global Recombinant Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombinant Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombinant Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Recombinant Vaccines Manufacturer Market Share in 2022
3.5 Recombinant Vaccines Market: Overall Company Footprint Analysis
3.5.1 Recombinant Vaccines Market: Region Footprint
3.5.2 Recombinant Vaccines Market: Company Product Type Footprint
3.5.3 Recombinant Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant Vaccines Market Size by Region
4.1.1 Global Recombinant Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Recombinant Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Recombinant Vaccines Average Price by Region (2018-2029)
4.2 North America Recombinant Vaccines Consumption Value (2018-2029)
4.3 Europe Recombinant Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant Vaccines Consumption Value (2018-2029)
4.5 South America Recombinant Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Recombinant Vaccines Consumption Value by Type (2018-2029)
5.3 Global Recombinant Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Recombinant Vaccines Consumption Value by Application (2018-2029)
6.3 Global Recombinant Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Recombinant Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Recombinant Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Recombinant Vaccines Market Size by Country
7.3.1 North America Recombinant Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Recombinant Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Recombinant Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Recombinant Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant Vaccines Market Size by Country
8.3.1 Europe Recombinant Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombinant Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombinant Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant Vaccines Market Size by Region
9.3.1 Asia-Pacific Recombinant Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombinant Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Recombinant Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Recombinant Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Recombinant Vaccines Market Size by Country
10.3.1 South America Recombinant Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Recombinant Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombinant Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant Vaccines Market Size by Country
11.3.1 Middle East & Africa Recombinant Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Recombinant Vaccines Market Drivers
12.2 Recombinant Vaccines Market Restraints
12.3 Recombinant Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Vaccines
13.3 Recombinant Vaccines Production Process
13.4 Recombinant Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Vaccines Typical Distributors
14.3 Recombinant Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc Major Business
Table 5. Merck & Co., Inc Recombinant Vaccines Product and Services
Table 6. Merck & Co., Inc Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck & Co., Inc Recent Developments/Updates
Table 8. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Green Cross Corporation Major Business
Table 10. Green Cross Corporation Recombinant Vaccines Product and Services
Table 11. Green Cross Corporation Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Green Cross Corporation Recent Developments/Updates
Table 13. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc. Major Business
Table 15. Pfizer Inc. Recombinant Vaccines Product and Services
Table 16. Pfizer Inc. Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Inc. Recent Developments/Updates
Table 18. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 19. Bayer AG Major Business
Table 20. Bayer AG Recombinant Vaccines Product and Services
Table 21. Bayer AG Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer AG Recent Developments/Updates
Table 23. Sanofi S A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S A. Major Business
Table 25. Sanofi S A. Recombinant Vaccines Product and Services
Table 26. Sanofi S A. Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi S A. Recent Developments/Updates
Table 28. Protein Science Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Protein Science Corporation Major Business
Table 30. Protein Science Corporation Recombinant Vaccines Product and Services
Table 31. Protein Science Corporation Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Protein Science Corporation Recent Developments/Updates
Table 33. GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table 34. GlaxoSmithKline Plc. Major Business
Table 35. GlaxoSmithKline Plc. Recombinant Vaccines Product and Services
Table 36. GlaxoSmithKline Plc. Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. GlaxoSmithKline Plc. Recent Developments/Updates
Table 38. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 39. Novartis AG Major Business
Table 40. Novartis AG Recombinant Vaccines Product and Services
Table 41. Novartis AG Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Novartis AG Recent Developments/Updates
Table 43. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Bharat Biotech Major Business
Table 45. Bharat Biotech Recombinant Vaccines Product and Services
Table 46. Bharat Biotech Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bharat Biotech Recent Developments/Updates
Table 48. Global Recombinant Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Recombinant Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Recombinant Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 51. Market Position of Manufacturers in Recombinant Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Recombinant Vaccines Production Site of Key Manufacturer
Table 53. Recombinant Vaccines Market: Company Product Type Footprint
Table 54. Recombinant Vaccines Market: Company Product Application Footprint
Table 55. Recombinant Vaccines New Market Entrants and Barriers to Market Entry
Table 56. Recombinant Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Recombinant Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Recombinant Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Recombinant Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Recombinant Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Recombinant Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 62. Global Recombinant Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 63. Global Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Recombinant Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Recombinant Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Recombinant Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 68. Global Recombinant Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 69. Global Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Recombinant Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Recombinant Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Recombinant Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 74. Global Recombinant Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 75. North America Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Recombinant Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Recombinant Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Recombinant Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Recombinant Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Recombinant Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Recombinant Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Recombinant Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Recombinant Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Recombinant Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Recombinant Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Recombinant Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Recombinant Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Recombinant Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Recombinant Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Recombinant Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Recombinant Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Recombinant Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Recombinant Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Recombinant Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Recombinant Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Recombinant Vaccines Raw Material
Table 116. Key Manufacturers of Recombinant Vaccines Raw Materials
Table 117. Recombinant Vaccines Typical Distributors
Table 118. Recombinant Vaccines Typical Customers
Table 1. Global Recombinant Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc Major Business
Table 5. Merck & Co., Inc Recombinant Vaccines Product and Services
Table 6. Merck & Co., Inc Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck & Co., Inc Recent Developments/Updates
Table 8. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Green Cross Corporation Major Business
Table 10. Green Cross Corporation Recombinant Vaccines Product and Services
Table 11. Green Cross Corporation Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Green Cross Corporation Recent Developments/Updates
Table 13. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Inc. Major Business
Table 15. Pfizer Inc. Recombinant Vaccines Product and Services
Table 16. Pfizer Inc. Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Inc. Recent Developments/Updates
Table 18. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 19. Bayer AG Major Business
Table 20. Bayer AG Recombinant Vaccines Product and Services
Table 21. Bayer AG Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer AG Recent Developments/Updates
Table 23. Sanofi S A. Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi S A. Major Business
Table 25. Sanofi S A. Recombinant Vaccines Product and Services
Table 26. Sanofi S A. Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi S A. Recent Developments/Updates
Table 28. Protein Science Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Protein Science Corporation Major Business
Table 30. Protein Science Corporation Recombinant Vaccines Product and Services
Table 31. Protein Science Corporation Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Protein Science Corporation Recent Developments/Updates
Table 33. GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table 34. GlaxoSmithKline Plc. Major Business
Table 35. GlaxoSmithKline Plc. Recombinant Vaccines Product and Services
Table 36. GlaxoSmithKline Plc. Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. GlaxoSmithKline Plc. Recent Developments/Updates
Table 38. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 39. Novartis AG Major Business
Table 40. Novartis AG Recombinant Vaccines Product and Services
Table 41. Novartis AG Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Novartis AG Recent Developments/Updates
Table 43. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Bharat Biotech Major Business
Table 45. Bharat Biotech Recombinant Vaccines Product and Services
Table 46. Bharat Biotech Recombinant Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Bharat Biotech Recent Developments/Updates
Table 48. Global Recombinant Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Recombinant Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Recombinant Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 51. Market Position of Manufacturers in Recombinant Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Recombinant Vaccines Production Site of Key Manufacturer
Table 53. Recombinant Vaccines Market: Company Product Type Footprint
Table 54. Recombinant Vaccines Market: Company Product Application Footprint
Table 55. Recombinant Vaccines New Market Entrants and Barriers to Market Entry
Table 56. Recombinant Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Recombinant Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Recombinant Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Recombinant Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Recombinant Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Recombinant Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 62. Global Recombinant Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 63. Global Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Recombinant Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Recombinant Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Recombinant Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 68. Global Recombinant Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 69. Global Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Recombinant Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Recombinant Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Recombinant Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 74. Global Recombinant Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 75. North America Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Recombinant Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Recombinant Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Recombinant Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Recombinant Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Recombinant Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Recombinant Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Recombinant Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Recombinant Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Recombinant Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Recombinant Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Recombinant Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Recombinant Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Recombinant Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Recombinant Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Recombinant Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Recombinant Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Recombinant Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Recombinant Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Recombinant Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Recombinant Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Recombinant Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Recombinant Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Recombinant Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Recombinant Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Recombinant Vaccines Raw Material
Table 116. Key Manufacturers of Recombinant Vaccines Raw Materials
Table 117. Recombinant Vaccines Typical Distributors
Table 118. Recombinant Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Recombinant Vaccines Picture
Figure 2. Global Recombinant Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Subunit Recombinant Vaccines Examples
Figure 5. Attenuated Recombinant Vaccines Examples
Figure 6. Vector Recombinant Vaccines Examples
Figure 7. Global Recombinant Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Recombinant Vaccines Consumption Value Market Share by Application in 2022
Figure 9. Recombinant Human Vaccines Examples
Figure 10. Animal Recombinant Vaccines Examples
Figure 11. Global Recombinant Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Recombinant Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Recombinant Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Recombinant Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Recombinant Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Recombinant Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Recombinant Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Recombinant Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Recombinant Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Recombinant Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Recombinant Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Recombinant Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Recombinant Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Recombinant Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Recombinant Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Recombinant Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Recombinant Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Recombinant Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Recombinant Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Recombinant Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Recombinant Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Recombinant Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Recombinant Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Recombinant Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Recombinant Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Recombinant Vaccines Market Drivers
Figure 74. Recombinant Vaccines Market Restraints
Figure 75. Recombinant Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Recombinant Vaccines in 2022
Figure 78. Manufacturing Process Analysis of Recombinant Vaccines
Figure 79. Recombinant Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Recombinant Vaccines Picture
Figure 2. Global Recombinant Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Subunit Recombinant Vaccines Examples
Figure 5. Attenuated Recombinant Vaccines Examples
Figure 6. Vector Recombinant Vaccines Examples
Figure 7. Global Recombinant Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Recombinant Vaccines Consumption Value Market Share by Application in 2022
Figure 9. Recombinant Human Vaccines Examples
Figure 10. Animal Recombinant Vaccines Examples
Figure 11. Global Recombinant Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Recombinant Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Recombinant Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Recombinant Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Recombinant Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Recombinant Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Recombinant Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Recombinant Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Recombinant Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Recombinant Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Recombinant Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Recombinant Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Recombinant Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Recombinant Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Recombinant Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Recombinant Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Recombinant Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Recombinant Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Recombinant Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Recombinant Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Recombinant Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Recombinant Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Recombinant Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Recombinant Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Recombinant Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Recombinant Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Recombinant Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Recombinant Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Recombinant Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Recombinant Vaccines Market Drivers
Figure 74. Recombinant Vaccines Market Restraints
Figure 75. Recombinant Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Recombinant Vaccines in 2022
Figure 78. Manufacturing Process Analysis of Recombinant Vaccines
Figure 79. Recombinant Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
